Related Experiment Video
Updated: Jul 3, 2026

16:24
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Published on: February 21, 2014
Apparently low reproducibility of true differential expression discoveries in microarray studies
Min Zhang1, Chen Yao, Zheng Guo
1School of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150086, China.
Bioinformatics (Oxford, England)
|July 18, 2008
Summary
Microarray gene expression studies show low reproducibility due to measurement variations, not poor technology. Individual gene lists may still be accurate, requiring new metrics for evaluating discoveries in complex diseases.
Area of Science:
- Genomics
- Bioinformatics
- Molecular Biology
Background:
- Gene expression analysis from microarray studies often yields inconsistent results for the same disease.
- Low reproducibility is observed even in technical replicates, leading to concerns about false discoveries in small studies.
Purpose of the Study:
- To investigate the causes of low reproducibility in differentially expressed gene (DEG) detection.
- To evaluate the reliability of DEG lists from microarray data.
- To propose new methods for assessing reproducibility in complex disease studies.
Main Methods:
- Development and application of a statistical model to analyze DEG detection reproducibility.
- Analysis of simulated and real cancer gene expression data.
- Assessment of false discovery rates (FDR) in DEG lists.
Main Results:
- Small measurement variations in technical replicates cause significant inconsistency in DEG lists.
- Heterogeneous biological variations in cancer data further decrease reproducibility.
- Despite low reproducibility, individual DEG lists often have a low FDR, indicating a high proportion of true discoveries.
- Existing methods for comparing DEG lists are insufficient for complex diseases.
Conclusions:
- Low reproducibility in DEG detection does not necessarily imply low microarray technology quality.
- Biological variability significantly impacts DEG detection reproducibility.
- Novel metrics are needed to evaluate the reproducibility of molecular discoveries in complex diseases, considering correlated changes.

